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Abstract
Background—Coagulase-negative staphylococci (CoNS) are the most commonly isolated
pathogens in the neonatal intensive care unit (NICU). CoNS infections are associated with
increased morbidity including neurodevelopmental impairment.
Objective—Describe the epidemiology of CoNS infections in the NICU. Determine mortality
among infants with definite, probable, or possible CoNS infections.
Methods—We performed a retrospective cohort study of all blood, urine, and cerebrospinal fluid
cultures from infants <121 postnatal days.
Setting—248 NICUs managed by the Pediatrix Medical Group from 1997 to 2009.
Results—We identified 16,629 infants with 17,624 episodes of CoNS infection: 1734 (10%)
definite, 3093 (17%) probable, and 12,797 (73%) possible infections. Infants with lower
gestational age and birth weight had a higher incidence of CoNS infection. Controlling for
gestational age, birth weight, and 5-minute Apgar score, infants with definite, probable, or
possible CoNS infection had lower mortality—OR=0.74 (95% confidence interval; 0.61, 0.89),
OR= 0.68 (0.59, 0.79), and OR=0.69 (0.63, 0.76)—compared to infants with negative cultures
(P<0.001). No significant difference in overall mortality was found in infants with definite CoNS
infection compared to those with probable or possible CoNS infection—OR=0.93 (0.75, 1.16) and
OR=0.85 (0.70, 1.03), respectively.
Conclusions—CoNS infection was strongly related to lower gestational age and birth weight.
Infants with clinical sepsis and culture-positive CoNS infection had lower mortality rates than
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infants with clinical sepsis and negative blood culture results. No difference in mortality between
infants diagnosed with definite, probable, or possible CoNS infection was observed.
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Coagulase-negative staphylococci (CoNS) are the most commonly isolated pathogens in the
neonatal intensive care unit (NICU).1–3 CoNS typically demonstrate low virulence1,2 but are
associated with morbidities in the premature infant, including chronic lung disease and
adverse neurodevelopmental outcomes.2, 4–9 CoNS infections are also associated with
prolonged hospital stay and increased hospital costs.10
These organisms are skin commensals, and isolation in culture may reflect culture
contamination. Several definitions of CoNS sepsis exist. Repeated isolation of CoNS from
blood cultures may represent contamination if samples are obtained >1 day after institution
of appropriate antibiotic therapy.11 Some investigators have defined CoNS infection as
either two positive blood cultures drawn within two days of each other or one positive blood
culture and observed elevated C-reactive protein within two days of the CoNS positive
culture.2 For patients <1 year of age, the Centers for Disease Control and Prevention defines
CoNS infection as the presence of clinical sepsis (e.g., hyperthermia, hypothermia, apnea, or
bradycardia) and isolation of CoNS organisms, either cultured from two or more blood
cultures drawn on separate occasions or obtained from at least one blood culture in a patient
with an intravascular line, where the physician begins appropriate antimicrobial therapy.12
The common objective of these various definitions is to distinguish CoNS infection from
CoNS contaminant.
In the following study, we sought to describe the epidemiology of CoNS infection in the
NICU and determine the mortality for infants with definite, probable, or possible CoNS
infection in a large cohort of infants. We hypothesized that infants with definite CoNS
infection would have lower gestational age, lower birth weight, and higher mortality than
infants with probable or possible CoNS infection.
METHODS
Study Design and Setting
We identified all blood, cerebrospinal fluid (CSF), and urine cultures obtained from a cohort
of infants <121 postnatal days admitted to 248 NICUs in the United States managed by the
Pediatrix Medical Group between 1997 and 2009. The database was created using a
computer-assisted tool that generates clinical progress notes. We collected demographic
information as reported in the clinical progress note including: birth weight, gestational age,
sex, maternal race/ethnicity, 5-minute Apgar score, maternal age, method of delivery
(vaginal vs. Cesarean section), place of delivery (inborn vs. outborn), presence of
mechanical ventilation, use of antenatal steroids, and exposure to antenatal antibiotics.
Cultures were processed according to the protocols at each hospital’s clinical microbiology
laboratory. We included urine cultures obtained by any method of collection (suprapubic
tap, in-and-out catheterization, bag specimen).
Definitions
Using previously reported criteria, we defined CoNS infection in one of three ways: definite
CoNS infection as two positive cultures drawn on the same day11; probable CoNS infection
as two positive cultures within a four-day period, three positive cultures within a seven-day
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period, or four positive cultures within a ten-day period; and possible CoNS infection as a
culture positive for CoNS that did not meet criteria for definite or probable CoNS infection.2
We defined separate episodes of CoNS infection as positive CoNS cultures obtained >21
days following the previous positive CoNS culture. During data analysis, we defined
patients with multiple episodes of CoNS infection by their highest-ranking CoNS episode.
For example, a patient with one definite episode of CoNS and one possible episode of CoNS
infection was defined as having definite CoNS infection. We defined mortality as death that
occurred prior to discharge from the NICU.
Statistical Methods
The unit of observation used for analysis was the infant. We used univariable and
multivariable logistic regression with backward selection (P value for removal of 0.2) to
examine potential risk factors for definite or probable CoNS infection. We used logistic
regression to compare the risk of death between infants with CoNS infection and those with
negative blood cultures, and to evaluate the relationship between duration of CoNS infection
and mortality adjusting for gestational age, birth weight, and 5-minute Apgar score. STATA
10 (College Station, TX) was used to perform all statistical analyses. Significance for all
tests was established at a P value of <0.05. Permission to conduct this analysis was provided
by the Duke University Institutional Review Board.
RESULTS
Study Population
From 1997 through 2009, the Pediatrix Medical Group cared for a total of 527,518 infants.
Of these, 388,331 infants had at least one blood, urine, or CSF culture, and 34,851 (9%) of
these infants had at least one positive blood, CSF, or urine culture. Of these infants, 16,629
(48%) had a total of 17,624 episodes of CoNS infection: 1734 (10%) definite, 3093 (17%)
probable, and 12,797 (73%) possible CoNS infections (Figure 1).
Demographics
Infants with definite, probable, or possible CoNS infection had lower gestational ages and
birth weights compared to infants with negative cultures (Table 1). Episodes of CoNS
infection decreased with increasing gestational age (Figure 2). The cumulative incidence of
definite, probable, or possible CoNS infection decreased from 5.4/1000 patient days at 23
weeks’ gestational age to 0.8/1000 patient days at 34 weeks’ gestational age. For birth
weight, the cumulative incidence of definite, probable, or possible CoNS infection decreased
from 4.5/1000 patient days in infants with birth weights of 600–699 g to 1.7/1000 patient
days in infants with birth weights of 1400–1499 g (Figure 3). The development of definite or
probable CoNS infection was strongly associated with lower birth weights (Table 2). On
multivariable analysis, gestational age and birth weight <750 g were associated with
development of definite or probable CoNS infection (Table 3). We found that infants with
higher birth weights had a decreased incidence of definite and probable CoNS infection—
OR=0.40 (95% confidence interval; 0.35, 0.46).
Onset of CoNS Infection
In this population, large numbers of possible CoNS infection were noted at birth but
decreased between day of life 0 and postnatal day 3 (Figure 4). The number of definite and
probable episodes of CoNS infection was highest between postnatal day 7 and postnatal day
14. The duration of positive cultures during episodes of CoNS infection ranged from one to
28 days; the median (10th, 90th percentile) duration of positive cultures in infants with
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definite, probable, or possible CoNS infection was 3 days (1, 14), 3 days (2, 12), and 1 day
(1, 1), respectively.
The majority of definite, probable, or possible episodes of CoNS infection were isolated
bloodstream infections (Table 4). Isolation of CoNS from blood and urine in the same
episode occurred in 11.5% of the episodes of definite CoNS infection. Diagnosis of definite
or probable CoNS infection from only urine, CSF, or a combination of both urine and CSF
was unusual; ≤1% of the episodes of definite or probable CoNS infection had only positive
urine, CSF, or a combination of both urine and CSF.
Mortality
The overall mortality for infants with definite, probable, and possible CoNS infection was
148/1500 (10%), 245/2588 (9%), and 643/10,575 (6%), respectively. After adjusting for
gestational age, birth weight, and 5-minute APGAR score, we found no difference in overall
mortality between infants with definite CoNS infection compared to those with probable
(OR=0.93 [0.75, 1.16]) or possible CoNS infection (OR=0.85 [0.70, 1.03]). We also found
that, compared to infants with negative cultures, infants with definite, probable, or possible
CoNS infection had lower mortality—OR=0.74 (0.61, 0.89), OR= 0.68 (0.59, 0.79), and
OR=0.69 (0.63, 0.76), respectively. Infants with positive CoNS cultures for >14 days had
increased mortality relative to infants with shorter durations of positive CoNS cultures
(OR=1.38 [1.08, 1.75]).
DISCUSSION
In this study, we found a strong association between CoNS infections and lower gestational
age and lower birth weight. This finding is consistent with previous studies.2,5 Preterm, low-
birth-weight infants are more likely to require prolonged use of central catheters, prolonged
use of parenteral nutrition, and mechanical ventilation—all risk factors for CoNS infection.
We found that episodes of CoNS infection increased in the second postnatal week, and we
found no difference in mortality between infants with definite, probable, or possible CoNS
infection. Most surprisingly, we found lower mortality in infants diagnosed with CoNS
compared to infants with negative cultures.
Consistent with our hypothesis, infants with the lowest gestational ages and birth weights
had the highest incidence of CoNS infection. Interestingly, we observed a slightly higher
incidence in CoNS infections in term infants (37–42 weeks’ gestation) compared to infants
born near-term (34–36 weeks’ gestation). Most of the observed increase was due to the
presence of possible CoNS infection. It is believed that this observation may be attributable
to the underlying reason for the infant’s admission to the NICU. Infants in the NICU at 34
weeks’ gestational age are there primarily for feeding and growth, but, beyond this
gestational age, the more likely it is that the infant has a serious underlying issue (e.g., a
congenital anomaly, respiratory difficulties) that may increase his/her susceptibility to CoNS
infection.
In our study, the highest incidence of CoNS infection was observed between postnatal day 7
and 14. This observation is consistent with findings from prior research4 and with the status
of CoNS as one of the primary pathogens isolated in late-onset sepsis.1,2, 13 CoNS infection
has been equated to a disease of medical advancement.14 The emergence of CoNS as a
nosocomial infection has coincided with the use of life-extending measures such as
intravascular catheters and mechanical ventilators, devices through which CoNS gains
access to normally sterile body fluids.15 In our study, the vast majority of CoNS infections
were isolated bloodstream infections, and only a small fraction of definite or probable CoNS
infections were attributed to urine or CSF culture. One explanation for this observation is
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that diagnosis of CoNS infection was made primarily through blood cultures with lumbar
punctures, and urine cultures are not always performed in infants with suspected infection in
the NICU. 16 It is possible that we have underestimated the true incidence of urinary tract
infections, as not all infants had urine obtained.
The similarity in mortality between infants with definite, probable, or possible CoNS sepsis
in our study may be attributed to the low virulence of CoNS. Specifically, CoNS may be
virulent enough to lead to increased morbidity,2, 4–9 but the organism is not sufficiently
virulent to cause mortality unless the bacteremia (organism burden) is prolonged. Previous
studies have documented an association between persistent recovery of pathogens from
normally sterile body sites and adverse outcomes including death.17–19 Prolonged infections
have been attributed to inappropriate antibiotic therapy or the delay in removal of
contaminated in-dwelling catheters.20 Although the mortality attributed to CoNS infection
compared to more virulent organisms historically has been significantly lower,1,2,21, 22 we
observed a higher mortality for infants with persistently positive culture (>14 days); this is
consistent with previous studies. Mortality is similar between CoNS and non-CoNS
pathogens (e.g., Staphylococcus aureus, Escherichia coli, Pseudomonas spp., Enterococcus
spp. Enterobacter cloacae) for prolonged infections.18
The finding that infants with CoNS infection had lower mortality than infants with negative
cultures may be attributable to an overestimation of the number of CoNS infections in this
cohort of infants. Although we used published criteria to define CoNS infection, we may
have overestimated the incidence of CoNS infection, particularly in the probable and
possible categories, as many neonatologists only obtain a single blood culture.23
Additionally, the small amount of blood (often <1 mL) obtained from infants for culture
increases the risk for false-negative blood culture results for other infections.24 Missing true
infections associated with increased mortality (Gram-negative rods and Candida) may also
account for the finding of increased mortality in infants with negative cultures compared to
those with CoNS infection.
Although several researchers have proposed algorithms for distinguishing between true
CoNS infections and contaminants,11, 25–28 no gold standard exists. Because presenting
signs are usually nonspecific, definitive diagnosis of CoNS infection in infants is difficult.29
Further complicating the diagnosis is the fact that CoNS are a component of normal skin
flora and thus can potentially contaminate blood cultures drawn peripherally or through
venous catheters.30 The inability to distinguish between infection and contamination can
lead to more laboratory tests, longer hospital stays, and unnecessary antibiotic
exposures.26, 31 As proposed by Zaidi et al., a possible solution would be to obtain two
peripheral blood cultures at the time of every sepsis evaluation.11
A strength of this study was the large sample size and diversity of NICUs included. We had
access to contemporary culture data from blood, urine, and CSF, allowing us to evaluate the
contributions of these cultures to the diagnosis of CoNS infection. This study was limited by
precise documentation of the timing and dosage of antimicrobial therapy. We also lacked
information about clinical signs of infection in the infant and the presence and removal of
central venous catheters. Collection of urine via bag method may have also increased the
risk of contamination relative to samples collected by in-and-out catheterization or
suprapubic tap. We made no attempt to relate CSF cultures to CSF parameters (glucose,
protein, white blood cell count) or urinalysis results and acknowledge that some positive
cultures may have represented skin contamination. Finally, we lacked information on site-
specific practices on skin disinfection (i.e., alcohol, chlorhexidine).
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In summary, we found that CoNS infection was strongly related to lower gestational age and
birth weight. We found no difference in mortality between infants diagnosed with definite,
probable, and possible CoNS infection. We also found lower mortality in infants with
clinical sepsis and CoNS positive cultures compared to infants with clinical sepsis and
negative cultures. Future studies focusing on the differences in morbidities between infants
with definite, probable, or possible CoNS infection are needed to further explore the long-
term effect of CoNS infection in infants in the NICU.
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Study population. CoNS, coagulase-negative staphylococcus; NICU, neonatal intensive care
unit.
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Coagulase-negative staphylococcal infection rates by gestational age—infants 23–42 weeks
per 1000 patient days. CoNS, coagulase-negative staphylococcus.
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Coagulase-negative staphylococcal infections by birth weight—infants 600–1499 g per 1000
patient days. CoNS, coagulase-negative staphylococcus.
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Coagulase-negative staphylococcal infection by day of life. CoNS, coagulase-negative
staphylococcus.
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Number of patients 1725 3004 11,900 370,538
Gestational age, n (%)
 <26 weeks 588 (32) 929 (31) 2185 (18) 8465 (2)
 26–28 weeks 570 (33) 1037 (35) 3070 (26) 19,004 (5)
 29–33 weeks 379 (22) 682 (23) 3175 (27) 91,810 (25)
 34–36 weeks 102 (6) 138 (5) 1269 (11) 111,301 (30)
 ≥37 weeks 115 (7) 216 (7) 2180 (18) 139,541 (38)
Birth weight, n (%)
 <750 g 564 (33) 952 (32) 2223 (19) 8438 (2)
 750–1000 g 461 (27) 778 (26) 2305 (19) 12,751 (3)
 1001–1500 g 382 (22) 710 (24) 2648 (22) 36,696 (10)
 1501–2000 g 115 (7) 208 (7) 1258 (11) 62,336 (17)
 2001–3500 g 169 (10) 286 (10) 2633 (22) 196,821 (53)
 >3500 g 33 (2) 67 (2) 810 (7) 52,770 (14)
Race/ethnicity, n (%)
 White 795 (47) 1337 (46) 5349 (46) 187,544 (53)
 African American 422 (25) 681 (23) 2462 (21) 60,800 (17)
 Hispanic 396 (23) 778 (27) 3171 (28) 90,054 (25)
 Other 82 (5) 114 (4) 524 (5) 17,642 (5)
Sex, n (%)
 Male 947 (55) 1604 (53) 6786 (57) 209,067 (56)
5-minute Apgar score, n (%)
 <3 95 (6) 147 (5) 420 (4) 5384 (1)
 4–6 368 (22) 609 (21) 1754 (15) 23,141 (6)
 7–10 1235 (73) 2195 (74) 9432 (81) 334,190 (92)
Mechanical ventilation day of life 1, n (%) 1268 (79) 2189 (80) 6632 (64) 75,186 (22)
Cesarean delivery, n (%) 1167 (68) 2058 (69) 7488 (64) 198,688 (54)
Inborn, n (%) 1343 (79) 2291 (78) 9080 (78) 312,222 (86)
Maternal age, n (%)
 10–19 years 274 (16) 410 (14) 1681 (14) 44,921 (12)
 20–29 years 868 (51) 1523 (51) 6005 (51) 186,062 (50)
 30–39 years 517 (30) 965 (32) 3803 (32) 126,113 (34)
 ≥40 years 57 (3) 97 (3) 355 (3) 11,845 (3)
Antenatal steroids, n (%) 1148 (67) 1983 (66) 6264 (53) 108,397 (29)
Antenatal antibiotics, n (%) 729 (42) 1316 (44) 4612 (39) 135,130 (36)
NOTE. CoNS, coagulase-negative staphylococcus.
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Table 2
Association of Birth Weight with Development of Definite or Probable CoNS Infection






NOTE. CoNS, coagulase-negative staphylococcus;
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TABLE 3
Risk Factors for CoNS Sepsis
Univariable analysis
Odds ratio (95% CI)
Multivariable analysis
Odds ratio (95% CI)
Birth weight (g)
 ≥1500 1.00 (REF) 1.00 (REF)
 1250–1499 6.62 (5.87, 7.46)
 1000–1249 14.43 (13.06, 15.96)
 750–999 30.05 (27.52, 32.82)
 <750 51.23 (47.04, 55.80) 1.56 (1.49, 1.63)
Gestational age (weeks) 0.71 (0.70, 0.71) 0.87 (0.86, 0.89)
Sex
 Female 1.00 (REF) 1.00 (REF)
 Male 0.91 (0.85, 0.96) 1.06 (0.99, 1.14)
5-minute APGAR score
 0–3 1.00 (REF)
 4–6 0.94 (0.82, 1.09)
 7–10 0.24 (0.21, 0.27)
Ventilator on day 1
 No 1.00 (REF) 1.00 (REF)
 Yes 12.35 (11.48, 13.29) 2.28 (2.06, 2.54)
Birth method
 Vaginal birth 1.00 (REF) 1.00 (REF)
 Caesarean section 1.84 (1.73, 1.96) 1.12 (1.04, 1.22)
Antenatal steroids
 No 1.00 (REF) 1.00 (REF)
 Yes 4.57 (4.30, 4.86) 1.21 (1.11, 1.31)
Antenatal antibiotics
 No 1.00 (REF) 1.00 (REF)
 Yes 1.32 (1.25, 1.40) 1.47 (1.05, 2.06)
Premature rupture of membranes
 No 1.00 (REF) 1.00 (REF)
 Yes 0.36 (0.33, 0.38) 0.86 (0.79, 0.93)
Race/ethnicity
 White 1.00 (REF) 1.00 (REF)
 Black 1.58 (1.47, 1.70)
 Hispanic 1.14 (1.06, 1.22) 1.23 (1.14, 1.33)
 Other 0.98 (0.84, 1.13)
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Blood only 1469 (84.7) 2927 (94.6) 11,756 (91.9)
Urine only 3 (0.2) 30 (1.0) 764 (6.0)
CSF only 7 (0.4) 32 (1.0) 216 (1.7)
Urine/CSF 1 (0.1) 1 (0.0) 1 (0.0)
Blood/urine 199 (11.5) 58 (1.9) 42 (0.3)
Blood/CSF 55 (3.2) 45 (1.5) 18 (0.1)
NOTE. CSF, cerebrospinal fluid; CoNS, coagulase-negative staphylococcus.
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